Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2024

Dec 12, 2024

33018_dirs_2024-12-11_6ba6b887-0701-427a-8cdb-8f8f9bc53f74.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2024-12-09

Reporting Person: OBRIEN MORGAN E (Director, Executive Chairman)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-12-09 Common Stock M 90000 $25 Acquired 113973 Direct
2024-12-09 Common Stock F 76391 $34.05 Disposed 37582 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-12-09 Stock Option (Right to Buy) $25 M 90000 Disposed 2025-01-29 Common Stock (90000) Direct

Footnotes

F1: This price reflects the closing price of the Issuer's Common Stock on the Nasdaq Capital Market on December 9, 2024.

F2: The option shares are fully vested and the option would have expired by its terms on January 29, 2025.